Danaher Corporation Unveils Two New Centers of Innovation to Revolutionize Precision Medicine Development

Published on :

Danaher Corporation Unveils Two New Centers of Innovation to Revolutionize Precision Medicine Development Danaher Corporation announces the launch of two CLIA and CAP-certified laboratories aimed at accelerating the development and [….]

Spotlight Your Start-up: Apply to Compete in the 9th Annual Crab Trap Competition

Published on :

Spotlight Your Start-up: Apply to Compete in the 9th Annual Crab Trap Competition July 17, 2024 Get ready to showcase your start-up at the BioHealth Capital Region Week! The 9th [….]

Unraveling the Mystery of Mayaro Virus: How Primates are Helping Scientists Predict and Prevent Future Outbreaks

Published on :

Unraveling the Mystery of Mayaro Virus: How Primates are Helping Scientists Predict and Prevent Future Outbreaks Researchers at BIOQUAL and Virginia Tech have pioneered a breakthrough by infecting non-human primates [….]

QIAGEN Celebrates Major Expansion in Frederick County

Published on :

QIAGEN Celebrates Major Expansion in Frederick County QIAGEN is expanding its operations in Frederick County, Maryland, adding 40,000 square feet to support its innovative work in life sciences and molecular [….]

Sneha Saggurthi Joins Cartesian Therapeutics as Training Program Manager

Published on :

Sneha Saggurthi Joins Cartesian Therapeutics as Training Program Manager July 11, 2024 Sneha Saggurthi joins Cartesian Therapeutics as Training Program Manager. Saggurthi brings a wealth of experience in optimizing manufacturing [….]

Maryland Aims to Lead the Nation in Federal Research Commercialization with Newly Funded Program

Published on :

Maryland Aims to Lead the Nation in Federal Research Commercialization with Newly Funded Program TEDCO collaborates with the Frederick Innovation Technology Center to improve Federal technology commercialization.   July 10, 2024 [….]

Cartesian Therapeutics Secures $130 Million in PIPE Financing Amid Announcement of First Patient Dosed in Phase 2 Trial for mRNA Cell Therapy

Published on :

Cartesian Therapeutics Secures $130 Million in PIPE Financing Amid Announcement of First Patient Dosed in Phase 2 Trial for mRNA Cell Therapy Cartesian Therapeutics, Inc. has secured $130 million in [….]